Fireside Chat: The Future, Under Your Skin – Why Subcutaneous Technology is the Next Frontier in Medicine

Session details:

What if one of the most revolutionary forces in medicine wasn’t a new drug, but a new way of delivering it? Subcutaneous (SC) drug delivery is quietly reshaping the future of healthcare, turning hours-long infusions into minutes-long injections. In doing so, emerging data makes clear that it has the potential to redefine efficacy, safety, access, cost, and more for many treatments. Dr. Helen Torley, President and CEO of Halozyme Therapeutics, will share how SC technology is the unseen engine powering blockbuster therapies that treat cancer, multiple sclerosis, and other chronic diseases, and why it is poised to drive the next era of biotech innovation—expanding the reach of lifechanging medicines and reimagining how treatment will look in the years ahead.

• Learn how delivery innovations and technologies are generating efficiencies that will transform the infrastructure of care across providers, payers, and systems worldwide
• Understand the disruptive trends – market demand, scientific advances, regulatory and policy change, and more – that will define the trajectory of adoption at scale
• Discover how replacing IV infusions with high-volume, rapid SC injections is establishing a new standard for the patient experience of tomorrow and the economics of care